Gemmer Asset Management LLC Novo Nordisk A S Transaction History

Gemmer Asset Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$103.24 - $121.81 $10,427 - $12,302	-101 Closed	0 $0
Q2 2020 Jul 31, 2020	BUY	$58.54 - $67.94 $468 - $543	8 Added 8.6%	101 $7,000
Q1 2020 May 01, 2020	BUY	$49.46 - $64.78 $395 - $518	8 Added 9.41%	93 $5,000
Q4 2019 Jan 17, 2020	SELL	$49.86 - $58.26 $598 - $699	-12 Reduced 12.37%	85 $5,000
Q3 2019 Oct 11, 2019	BUY	$47.54 - $53.43 $570 - $641	12 Added 14.12%	97 $5,000
Q4 2018 Jan 18, 2019	BUY	$41.54 - $47.25 $83 - $94	2 Added 2.41%	85 $4,000
Q3 2018 Oct 12, 2018	SELL	$46.76 - $51.24 $2,291 - $2,510	-49 Reduced 37.12%	83 $4,000
Q2 2018 Jul 18, 2018	BUY	$44.29 - $50.42 $974 - $1,109	22 Added 20.0%	132 $6,000
Q1 2018 May 11, 2018	BUY	$48.49 - $58.14 $484 - $581	10 Added 10.0%	110 $5,000
Q4 2017 Jan 16, 2018	BUY	$47.53 - $53.73 $4,753 - $5,373	100	100 $5,000

1,988

318M

5.16M

4.97M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $260B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Gemmer Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Gemmer Asset Management LLC with notifications on news.